Effect of Carbonated Soft Drinks on the Body Weight
- Conditions
- ObesityMetabolic; ComplicationsDietary Habits
- Interventions
- Other: Semi-skimmed milkOther: Aspartame-sweetened soft drinkOther: WaterOther: Sugar-sweetened soft drink
- Registration Number
- NCT00777647
- Lead Sponsor
- Aarhus University Hospital
- Brief Summary
Compared to solid foods, the nutritional energy of drinks may bypass the appetite regulation leading to obesity development. Although drinks sweetened with aspartame are available the anticipated positive effect of these drinks on obesity development has not been convincing. However, the mechanisms linking drinks intake to obesity are yet to be clarified.
The investigators aim is to investigate the long-term effects of intake of soft drinks, milk and water. The study is a parallel, intervention trial with 80 overweight, healthy volunteers. They will be randomly selected to drink one liter a day of one of the four drinks for six months. The objectives are changes in numerous circulating metabolic risk factors, changes in body weight, anthropometric data and fat distribution (measured by DEXA, MRI and MR-spectroscopy).
The investigators expect to clarify the mechanisms linking drinking habits to obesity development and provide scientifically based nutritional guidelines.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Age between 20-50 years;
- BMI between 28-36 kg/m2;
- Weight stabile 3 months prior to the study inclusion;
- Less than 10 hours of weekly exercise
- Diabetes
- Allergic to phenylalanine or milk
- Smoking
- Pregnancy or breast-feeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Semi-skimmed milk Semi-skimmed milk 202kJ/100mL Aspartame-sweetened soft drink Aspartame-sweetened soft drink 1.5kJ/100mL Water Water 0kJ/100mL Sugar-sweetened soft drink Sugar-sweetened soft drink 54g sugar/L, 180kJ/100mL
- Primary Outcome Measures
Name Time Method Body Weight (kg) Six months MR spectroscopy Six months to assess liver fat and skeletal muscle fat
Dual-energy X-ray absorptiometry (DEXA) scan Six months to assess total fat mass (kg), lean body mass (kg), and bone mass (kg)
Magnetic resonance imaging Six months to assess visceral adipose tissue (VAT) and subcutaneous abdominal adipose tissue (SAAT)
- Secondary Outcome Measures
Name Time Method Fasting plasma PAI-1 Six months ng/ml
fasting serum insulin Six months pmol/L
Blood pressure Six months Systolic and diastolic blood pressure (mmHg)
Circulating metabolic parameters: including serum urate Six months mmol/L
Oral Glucose Tolerance Test (OGTT) Six months AUC OGTT glucose and insulin, AUC HOMA-IR, and Matzuda index
Fasting plasma FFA Six months mmol/L
fasting plasma glucose Six months mmol/L
Fasting blood lipids Six months Total, LDL, and HDL cholesterol, and TAG (mmol/L)
Trial Locations
- Locations (1)
Department of Internal Medicine/Endocrinology C, Aarhus University Hospital
🇩🇰Aarhus, Denmark